Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07052409

Developing Interventions for Protecting HIV-Exposed Uninfected Infants Against Severe Infections

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
72 (estimated)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
6 Months – 45 Years
Healthy volunteers
Not accepted

Summary

Research has shown that babies who are exposed to HIV, but are uninfected (negative HIV status), have a bigger risk of developing severe infections. There are naturally occurring organisms in the gut that may determine how the body protects itself against infections. These organisms may be different in babies who were exposed to the HIV virus in utero, compared to those who were not exposed. This study wants to see if the organisms in the gut of babies can be modified by supplementing the diet of the pregnant mother or of the baby at 6 months of age with Inkomasi (pasteurized fermented milk). The study will compare the type and amount of organisms in those who received supplementation and those who did not receive supplementation.

Detailed description

1. The study will enroll 24 pregnant women with HIV at 36 weeks gestational age and randomize them 1:1 to receive 500 ml daily of pasteurized fermented milk (Inkomasi) or not. Changes in maternal gut microbiota from enrollment to 2-4 weeks postpartum will be compared between groups. The study will also compare the gut microbiome at infants born to mothers who received Inkomasi with those born to mothers who did not receive Inkomasi. 2. The study will enroll 24 HIV-exposed uninfected infants (HEU) at 24 weeks of age and randomize them 1:1 to receive ≥15 ml daily of pasteurized fermented milk (Inkomasi) or not. Changes in infant gut microbiota from enrollment to 4 weeks after enrollment will be compared between groups.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTInkomaziPasteurized fermented milk

Timeline

Start date
2025-04-10
Primary completion
2028-06-01
Completion
2029-07-01
First posted
2025-07-04
Last updated
2025-07-09

Locations

1 site across 1 country: South Africa

Source: ClinicalTrials.gov record NCT07052409. Inclusion in this directory is not an endorsement.